From: Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone
Total number
28
Age (years)
Median
64
Range
46 to 81
Gender
Male
15
Female
13
Primary tumor site
Extrahepatic bile duct
18
Gallbladder
10
Recurrence or unresectable
Recurrence after surgery
22
Unresectable
6